Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults
Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults
Active, not recruiting · NCT05210413 · Registry updated 2026-01-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults | Refractory or Recurrent Solid Tumor | Active, not recruiting | Phase 1 / Phase 2 | 2026-01-15 | NCT05210413 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondation ARC | 5 |
| National Cancer Institute, France | 61 |
| Novartis | 114 |
| University Hospital, Bordeaux | 221 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHM Hôpital des Enfants La Timone - Hématologie Oncologie Pédiatrique | Marseille | France | 1 |
| Centre Léon Bérard - Oncologie Médicale | Lyon | France | 1 |
| Centre Oscar Lambret - Oncologie pédiatrie | Lille | France | 1 |
| CHU d'Angers - Unité d'Hématologie et d'Oncologie pédiatrique | Angers | France | 1 |
| CHU de Bordeaux - Unité d'Hématologie et d'Oncologie pédiatrique | Bordeaux | France | 1 |
| Curie Institute | Paris | France | 1 |
| Gustave Roussy - Oncologie pédiatrique | Villejuif | France | 1 |
| Institut Bergonié - Oncologie Médicale | Bordeaux | France | 1 |
| Institut Curie - Centre D'Oncologie SIREDO | Paris | France | 1 |
| Institut d'Hématologie et d'Oncologie Pédiatrique (IHOP) - Oncologie pédiatrique | Lyon | France | 1 |
| Nantes University Hospital | Nantes | France | 14 |
| Oscar Lambret Center | Lille | France | 1 |
| Strasbourg University Hospital | Strasbourg | France | 5 |